Eyerising International Pty Ltd
- 100% Optical
- Instruments (Ophthalmic)
- Lasers
- Low Vision Aids
- Equipment & Machinery
![Eyerising International Pty Ltd](https://cdn.asp.events/CLIENT_Media_10_B9D470DF_5056_B739_5443B4BBAA6F8ED4/sites/100-Optical/media/libraries/exhibitors/f8eecad5-5149-11ee-bff906bd0f937899-cover-image.jpg/fit-in/1500x9999/filters:no_upscale())
Eyerising International is leading the effort to control the progression of childhood Myopia with it’s world-first at-home device for Myopia control, the Eyerising Myopia Management Device, utelising Repeated Low-level Red Light (RLRL) Technology
Non–invasive, and without the need for medication, eyedrops or lenses, this technology is the only one on the market suitable for children as young as 3 years of age, when beginning control can have the best long-term impact.
The patented Eyerising Myopia Management Device, has been proven in published clinical trials to be the world's most effective Myopia treatment, dramatically reducing the progression of myopia by up to 87.7%.
Address
Suite 2.05 9/11Claremont St
South Yarra
3141
Australia
Contact Exhibitor
-
EyeRising International, an Australian MedTech company who have developed a Myopia Management Repeated Low-Level-Red-Light therapy. This innovative therapy has undergone clinical testing and has been ...
-
Eyerising Myopia Management Device emits low-level single-wavelength red-light to the ocular fundus of the patients through the pupil, which increases the blood flow
-
Australian MedTech company, Eyerising International, has rolled out a six-month UK pilot for its Eyerising myopia management device to 10 UK clinics.